These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38936976)

  • 1. NOSH-aspirin (NBS-1120) inhibits estrogen receptor negative breast cancer
    Chattopadhyay M; Nath N; Kodela R; Metkar S; Soyemi SA; Kashfi K
    J Pharmacol Exp Ther; 2024 Jun; ():. PubMed ID: 38936976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS.
    Chattopadhyay M; Kodela R; Santiago G; Le TTC; Nath N; Kashfi K
    Biochem Pharmacol; 2020 Jun; 176():113857. PubMed ID: 32061771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOSH-Aspirin Inhibits Colon Cancer Cell Growth: Effects Of Positional Isomerism.
    Vannini F; Kodela R; Chattopadhyay M; Kashfi K
    Redox Biol; 2015 Aug; 5():421. PubMed ID: 28162291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
    Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K
    Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility Of Nitric Oxide And Hydrogen Sulfide-Releasing Chimeras As Anticancer Agents.
    Kashfi K
    Redox Biol; 2015 Aug; 5():420. PubMed ID: 28162289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
    Chattopadhyay M; Kodela R; Olson KR; Kashfi K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid.
    Vannini F; MacKessack-Leitch AC; Eschbach EK; Chattopadhyay M; Kodela R; Kashfi K
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4677-82. PubMed ID: 26323873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
    Siraj MA; Jacobs AT; Tan GT
    Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders.
    Lee M; McGeer E; Kodela R; Kashfi K; McGeer PL
    Glia; 2013 Oct; 61(10):1724-34. PubMed ID: 23918470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals.
    Kodela R; Chattopadhyay M; Kashfi K
    ACS Med Chem Lett; 2012 Mar; 3(3):257-262. PubMed ID: 22916316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.
    Kashfi K; Chattopadhyay M; Kodela R
    Redox Biol; 2015 Dec; 6():287-296. PubMed ID: 26298203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain.
    Fonseca MD; Cunha FQ; Kashfi K; Cunha TM
    Pharmacol Res Perspect; 2015 Jun; 3(3):e00133. PubMed ID: 26236481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications.
    Kodela R; Chattopadhyay M; Velázquez-Martínez CA; Kashfi K
    Biochem Pharmacol; 2015 Dec; 98(4):564-72. PubMed ID: 26394025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential.
    Kodela R; Chattopadhyay M; Kashfi K
    Medchemcomm; 2013; 4(11):. PubMed ID: 24273639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling.
    Zhou H; Huang L; Sun Y; Rigas B
    Cancer Lett; 2009 Jan; 273(2):292-9. PubMed ID: 18805632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Potential of Nitric Oxide and Hydrogen Sulfide (NOSH)-Releasing Synthetic Compounds as Novel Priming Agents against Drought Stress in
    Antoniou C; Xenofontos R; Chatzimichail G; Christou A; Kashfi K; Fotopoulos V
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect.
    Zhao W; Mackenzie GG; Murray OT; Zhang Z; Rigas B
    Carcinogenesis; 2009 Mar; 30(3):512-9. PubMed ID: 19136474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.